Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2004-11-19
pubmed:abstractText
Based on the hypothesis that long-term fetomaternal microchimerism is associated with acquired immunologic hyporesponsiveness to noninherited maternal antigens (NIMAs) or inherited paternal antigens (IPAs), several groups have recently reported successful cases of non-T-cell-depleted hematopoietic stem cell transplantation (SCT) from HLA-haploidentical family members mismatched for NIMAs. In this study, we examined the outcomes of 35 patients with advanced hematologic malignancies who underwent HLA-2-antigen- or HLA-3-antigen-incompatible SCT from a microchimeric NIMA-mismatched donor. After standard-intensity or reduced-intensity preparative regimens, all patients had sustained hematopoietic recovery with tacrolimus-based graft-versus-host disease (GVHD) prophylaxis. Grade II/IV acute GVHD occurred in 19 (56%) of 34 evaluable patients, while extensive chronic GVHD developed in 13 (57%) of 23 patients who could be evaluated. Multivariate analysis demonstrated that NIMA mismatch in the GVH direction was associated with a lower risk of severe grade III-IV acute GVHD when compared with IPA mismatch (P = .03). Fifteen patients were alive and 14 of them were disease-free with a median follow-up of 20 (range, 8 to 37) months. These results indicate that T cell-replete SCT from an HLA-haploidentical NIMA-mismatched donor can offer durable remission with an acceptable risk of GVHD in selected patients with advanced hematologic malignancies who lack immediate access to a conventional stem cell source.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0006-4971
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
104
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
3821-8
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:15280193-Adolescent, pubmed-meshheading:15280193-Adult, pubmed-meshheading:15280193-Cause of Death, pubmed-meshheading:15280193-Child, pubmed-meshheading:15280193-Child, Preschool, pubmed-meshheading:15280193-Feasibility Studies, pubmed-meshheading:15280193-Female, pubmed-meshheading:15280193-Graft vs Host Disease, pubmed-meshheading:15280193-Haplotypes, pubmed-meshheading:15280193-Hematologic Neoplasms, pubmed-meshheading:15280193-Hematopoietic Stem Cell Transplantation, pubmed-meshheading:15280193-Histocompatibility, pubmed-meshheading:15280193-Histocompatibility Testing, pubmed-meshheading:15280193-Humans, pubmed-meshheading:15280193-Isoantigens, pubmed-meshheading:15280193-Male, pubmed-meshheading:15280193-Middle Aged, pubmed-meshheading:15280193-Mothers, pubmed-meshheading:15280193-Nuclear Family, pubmed-meshheading:15280193-Registries, pubmed-meshheading:15280193-Retrospective Studies, pubmed-meshheading:15280193-Survival Analysis, pubmed-meshheading:15280193-Tissue Donors, pubmed-meshheading:15280193-Transplantation Chimera
pubmed:year
2004
pubmed:articleTitle
Feasibility of HLA-haploidentical hematopoietic stem cell transplantation between noninherited maternal antigen (NIMA)-mismatched family members linked with long-term fetomaternal microchimerism.
pubmed:affiliation
Department of Hematology/Oncology, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan. nohe@kuhp.kyoto-u.ac.jp.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't